Reports for CHEPLAPHARM ARZNEIMITTEL GMBH

Company Name
CHEPLAPHARM ARZNEIMITTEL GMBH

Shortage reports

Actual shortage:

6 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

1 (1%)

Resolved:

74 (91%)

81

Discontinuation Reports

To be discontinued:

0 (0%)

Discontinued:

4 (57%)

Reversed:

3 (43%)

7

7 (8%)

2 (33%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
XENICAL 120MG CAPSULE Resolved 2021-05-13 2021-08-10 139254

Showing 81 to 81 of 81

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ANANDRON 50MG TABLET Reversed 2024-05-16 2024-07-10 228155
LOSEC 20MG TABLET (DELAYED-RELEASE) Discontinued 2021-11-19 2021-11-19 149669
SUPREFACT 100MCG SOLUTION Discontinued 2021-12-13 2021-12-13 151039
SUPREFACT DEPOT 2 MONTHS 6.3MG IMPLANT Reversed 2024-05-16 2024-06-19 228169
SUPREFACT DEPOT 3 MONTHS 9.45MG IMPLANT Reversed 2024-05-16 2024-07-10 228166
XELODA 150MG TABLET Discontinued 2022-11-30 2022-12-01 176355
XELODA 500MG TABLET Discontinued 2022-11-30 2022-12-01 176359

Showing 1 to 7 of 7